Michael Timaner

About Michael Timaner

Michael Timaner, With an exceptional h-index of 14 and a recent h-index of 14 (since 2020), a distinguished researcher at Technion - Israel Institute of Technology, specializes in the field of cancer, stem cells, immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Methods for treating acute respiratory inflammatory conditions and cytokine storm syndrome

Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors

Harnessing the therapeutic power of secretomes to treat IPF

Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors

T cells promote metastasis by regulating extracellular matrix remodeling following chemotherapy

RNF4~ RGMb~ BMP6 axis required for osteogenic differentiation and cancer cell survival

Tissue repair by activated cells

IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells

Michael Timaner Information

University

Position

___

Citations(all)

752

Citations(since 2020)

667

Cited By

297

hIndex(all)

14

hIndex(since 2020)

14

i10Index(all)

15

i10Index(since 2020)

15

Email

University Profile Page

Technion - Israel Institute of Technology

Google Scholar

View Google Scholar Profile

Michael Timaner Skills & Research Interests

cancer

stem cells

immunotherapy

Top articles of Michael Timaner

Title

Journal

Author(s)

Publication Date

Methods for treating acute respiratory inflammatory conditions and cytokine storm syndrome

2023/5/25

Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors

Oncogene

Avital Vorontsova

Tim J Cooper

Jozafina Haj-Shomaly

Madeleine Benguigui

Sapir Levin

...

2023/3/3

Harnessing the therapeutic power of secretomes to treat IPF

M Timaner

T Fishman-Jacob

B Pertzov

B Tadmor

J Laufer

...

2022/9/4

Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors

Frontiers in Immunology

Madeleine Benguigui

Avital Vorontsova

Michael Timaner

Sapir Levin

Jozafina Haj-Shomaly

...

2022/7/7

T cells promote metastasis by regulating extracellular matrix remodeling following chemotherapy

Cancer research

Jozafina Haj-Shomaly

Avital Vorontsova

Tamar Barenholz-Cohen

Oshrat Levi-Galibov

Mahesh Devarasetty

...

2022/1/15

RNF4~ RGMb~ BMP6 axis required for osteogenic differentiation and cancer cell survival

Cell Death & Disease

Rostislav Novak

Yamen Abu Ahmad

Michael Timaner

Eliya Bitman-Lotan

Avital Oknin-Vaisman

...

2022/9/24

Tissue repair by activated cells

2021/11/4

IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells

Journal for immunotherapy of cancer

Ksenia Magidey-Klein

Tim J Cooper

Ksenya Kveler

Rachelly Normand

Tongwu Zhang

...

2021

Tumor-educated monocyte-dendritic progenitors promote a metastatic switch

bioRxiv

Ksenia Magidey-Klein

Ksenya Kveler

Tim J Cooper

Rachelly Normand

Tongwu Zhang

...

2020/8/25

Elucidating the roles of ASPM isoforms reveals a novel prognostic marker for pancreatic cancer

The Journal of pathology

Michael Timaner

Yuval Shaked

2020/2

The multifaceted role of mesenchymal stem cells in cancer

Michael Timaner

Kelvin K Tsai

Yuval Shaked

2020/2/1

Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1

Oncogene

Michael Timaner

Ruslana Kotsofruk

Ziv Raviv

Ksenia Magidey

Dvir Shechter

...

2020/1/2

IL-31 induces antitumor immunity in breast carcinoma

Journal for ImmunoTherapy of Cancer

Tal Kan

Erik Feldman

Michael Timaner

Ziv Raviv

Shai Shen-Orr

...

2020

See List of Professors in Michael Timaner University(Technion - Israel Institute of Technology)